Personal Capital Advisors Corp raised its stake in Monsanto Company (NYSE:MON) by 11.5% during the second quarter, Holdings Channel reports. The institutional investor owned 171,318 shares of the basic materials company’s stock after buying an additional 17,711 shares during the period. Personal Capital Advisors Corp’s holdings in Monsanto were worth $20,277,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in MON. Whitnell & Co. boosted its position in Monsanto by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock valued at $111,000 after buying an additional 256 shares in the last quarter. Hartford Financial Management Inc. acquired a new position in Monsanto during the first quarter valued at about $113,000. Acrospire Investment Management LLC acquired a new position in Monsanto during the first quarter valued at about $113,000. JNBA Financial Advisors boosted its position in Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares in the last quarter. Finally, Penserra Capital Management LLC boosted its position in Monsanto by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock valued at $145,000 after buying an additional 112 shares in the last quarter. 75.31% of the stock is owned by institutional investors and hedge funds.

Shares of Monsanto Company (MON) traded down 0.33% during trading on Friday, hitting $116.55. The stock had a trading volume of 1,012,471 shares. Monsanto Company has a one year low of $97.35 and a one year high of $118.97. The firm has a market cap of $51.20 billion, a P/E ratio of 25.17 and a beta of 1.07. The firm’s 50-day moving average is $117.47 and its 200-day moving average is $115.08.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.19. The firm had revenue of $4.23 billion during the quarter, compared to analysts’ expectations of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. Monsanto’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same period in the prior year, the company posted $2.17 earnings per share. Equities research analysts forecast that Monsanto Company will post $4.89 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.85%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio is presently 46.75%.

COPYRIGHT VIOLATION NOTICE: “Personal Capital Advisors Corp Has $20.28 Million Stake in Monsanto Company (NYSE:MON)” was first reported by Daily Political and is the property of of Daily Political. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.dailypolitical.com/2017/08/12/personal-capital-advisors-corp-has-20-28-million-stake-in-monsanto-company-nysemon.html.

A number of analysts recently issued reports on the company. UBS AG cut Monsanto from a “positive” rating to a “neutral” rating in a research report on Tuesday, June 27th. Royal Bank Of Canada reissued a “hold” rating and issued a $128.00 target price on shares of Monsanto in a research report on Wednesday, August 2nd. Vetr cut Monsanto from a “buy” rating to a “hold” rating and set a $122.35 target price for the company. in a research report on Wednesday, August 2nd. Jefferies Group LLC cut Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price for the company. in a research report on Wednesday, July 12th. Finally, Barclays PLC upped their target price on Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a research report on Thursday, June 29th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the stock. Monsanto currently has a consensus rating of “Hold” and an average price target of $123.15.

In related news, EVP Robert T. Fraley sold 52,410 shares of the company’s stock in a transaction on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Janet M. Holloway sold 3,337 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $118.00, for a total transaction of $393,766.00. Following the completion of the sale, the senior vice president now owns 44,405 shares of the company’s stock, valued at $5,239,790. The disclosure for this sale can be found here. Insiders sold 74,470 shares of company stock valued at $8,791,281 over the last quarter. 0.79% of the stock is currently owned by corporate insiders.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.